In recent years, the field of interventional oncology has emerged as a critical component in the comprehensive treatment of cancer. Defined as a subspecialty of interventional radiology, interventional oncology (IO) utilizes minimally invasive procedures to diagnose, treat, and manage cancerous tumors. The global interventional oncology …
The global interventional oncology market is projected to experience robust growth in the coming years, driven by several key factors. Valued at $1.9 billion in 2020, this market is expected to reach $2.9 billion by 2026, growing at an impressive compound annual growth rate (CAGR) …
What This Report Will Provide? This study involved four major activities in estimating the current size of the interventional oncology market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to …
The growth of interventional oncology market is primarily driven by the rising preference for minimally invasive procedures, expansion of the target patient population, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and increasing government investments and …
According to the new market research report “Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) – Global Forecast to 2024“, published by MarketsandMarkets™, the Interventional Oncology Market is projected to reach USD …